0360-0156 : Drosera 6 [Hp_x]/G Sublingual Tablet
NDC: | 0360-0156 |
Labeler: | Standard Homeopathic Company |
Product Type: | Human OTC Drug |
Drug Name: | Drosera |
Dosage Form: | Sublingual Tablet |
Rev. Date: |
Appearance:
Shapes: |
Round |
Colors: |
White |
Size (mm): | 5 |
Segments: * | 0 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 0 indicates a scored pill which can be broken into 0 equal pieces. |
NDC Package Codes:
- 0360-0156-01: 1 G IN 1 BOTTLE, PLASTIC (0360‑0156‑01)
Active Ingredients:
- Drosera Anglica
Dosage Strength:
- 6 [hp_X]/g
Inactive Ingredients:
- Acacia
- Lactose Monohydrate
Related Products:
Based on records with the same trade name.- 0360-0157 Drosera 6 [Hp_x]/G Sublingual Tablet by Standard Homeopathic Company
- 0220-1784 Drosera 5 [Hp_c]/5[hp_c] Oral Pellet by Boiron
- 0220-1785 Drosera 6 [Hp_c]/6[hp_c] Oral Pellet by Boiron
- 0220-1788 Drosera 9 [Hp_c]/9[hp_c] Oral Pellet by Boiron
- 0220-1792 Drosera 12 [Hp_c]/12[hp_c] Oral Pellet by Boiron
- 0220-1793 Drosera 15 [Hp_c]/15[hp_c] Oral Pellet by Boiron
- 0220-1796 Drosera 30 [Hp_c]/30[hp_c] Oral Pellet by Boiron
- 0220-1797 Drosera 200 [Kp_c]/200[kp_c] Oral Pellet by Boiron
- 0220-1800 Drosera 1 [Hp_m]/[hp_m] Oral Pellet by Boiron
- 0220-1801 Drosera 30 [Hp_x]/30[hp_x] Oral Pellet by Boiron
- 53645-2000 Drosera 6 [Hp_x]/23g Oral Globule by True Botanica, LLC
- 53645-2001 Drosera 6 [Hp_x]/55ml Oral Liquid by True Botanica, LLC
- 62106-7919 Drosera 1 [hp_x]/1 Oral Granule by Seroyal USA
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0360-0151Next: 0360-0157 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.